Objectives

After participating in this educational activity, attendees should be able to:
1|Explain the purpose, scope, and regulatory role of USP <795>.
2|Differentiate key requirements (personnel, facilities, documentation, BUDs).
3|Apply USP <795> standards to real-world compounding scenarios.

Presenter(s): 
Madalyn Dankocsik, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Madalyn Dankocsik, PharmDSpeakerNo relevant relationships with ineligible companies to discloseNo
Session date: 
04/20/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid - Baystate Medical Center & Webinar
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.